Silence Therapeutics plc (SLN)
NASDAQ: SLN · Real-Time Price · USD
3.375
-0.135 (-3.85%)
Apr 25, 2025, 4:00 PM EDT - Market closed
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $158.67 million as of April 25, 2025. Its market cap has decreased by -83.87% in one year.
Market Cap
158.67M
Enterprise Value
11.46M
1-Year Change
-83.87%
Ranking
Category
Stock Price
$3.38
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from $538.37M to $158.67M, a decrease of -70.53%. That is a compound annual growth rate of -23.19%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 158.67M | -51.15% |
| Dec 31, 2024 | 324.84M | -51.64% |
| Dec 29, 2023 | 671.70M | 22.71% |
| Dec 30, 2022 | 547.37M | -23.44% |
| Dec 31, 2021 | 714.99M | 17.04% |
| Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 772.03B |
| UnitedHealth Group | 386.16B |
| Johnson & Johnson | 372.77B |
| AbbVie | 319.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 224.39B |
| AstraZeneca | 215.41B |
| Novartis AG | 210.89B |